CVS Health Corporation - Laporan Laba Rugi (TTM)

CVS Health Corporation
CH ˙ BRSE ˙ US1266501006
Laporan Laba Rugi (TTM)

Laporan Laba Rugi CVS Health Corporation menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 265,285 267,908 270,115 277,285 283,981 290,912 298,770 306,933 314,343 321,629 329,915 338,072 346,601 356,623 359,662 361,855 367,246 370,656 376,741 384,329
Change (%) 0.99 0.82 2.65 2.41 2.44 2.70 2.73 2.41 2.32 2.58 2.47 2.52 2.89 0.85 0.61 1.49 0.93 1.64 2.01
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 217,261 219,660 221,524 228,952 234,708 239,991 246,897 254,256 260,930 267,965 276,436 284,974 293,395 303,345 307,318 309,851 316,534 321,408 325,724 333,195
Change (%) 1.10 0.85 3.35 2.51 2.25 2.88 2.98 2.62 2.70 3.16 3.09 2.96 3.39 1.31 0.82 2.16 1.54 1.34 2.29
% of Revenue 81.90 81.99 82.01 82.57 82.65 82.50 82.64 82.84 83.01 83.31 83.79 84.29 84.65 85.06 85.45 85.63 86.19 86.71 86.46 86.70
Gross Operating Profit 48,024 48,248 48,591 48,333 49,273 50,921 51,873 52,677 53,413 53,664 53,479 53,098 53,206 53,278 52,344 52,004 50,712 49,248 51,017 51,134
Change (%) 0.47 0.71 -0.53 1.94 3.34 1.87 1.55 1.40 0.47 -0.34 -0.71 0.20 0.14 -1.75 -0.65 -2.48 -2.89 3.59 0.23
% of Revenue 18.10 18.01 17.99 17.43 17.35 17.50 17.36 17.16 16.99 16.69 16.21 15.71 15.35 14.94 14.55 14.37 13.81 13.29 13.54 13.30
SG&A 33,907 34,585 34,972 35,270 36,046 36,764 37,252 37,549 37,970 37,922 38,135 38,629 38,836 39,205 39,798 40,354 41,052 41,229 41,683 41,794
Change (%) 2.00 1.12 0.85 2.20 1.99 1.33 0.80 1.12 -0.13 0.56 1.30 0.54 0.95 1.51 1.40 1.73 0.43 1.10 0.27
% of Revenue 12.78 12.91 12.95 12.72 12.69 12.64 12.47 12.23 12.08 11.79 11.56 11.43 11.20 10.99 11.07 11.15 11.18 11.12 11.06 10.87
R&D
Change (%)
% of Revenue
OpEx 251,168 254,245 256,496 264,222 270,754 276,755 284,149 291,805 298,900 305,887 314,571 323,603 332,231 342,550 347,116 350,205 357,586 362,637 367,407 374,989
Change (%) 1.23 0.89 3.01 2.47 2.22 2.67 2.69 2.43 2.34 2.84 2.87 2.67 3.11 1.33 0.89 2.11 1.41 1.32 2.06
% of Revenue 94.68 94.90 94.96 95.29 95.34 95.13 95.11 95.07 95.09 95.11 95.35 95.72 95.85 96.05 96.51 96.78 97.37 97.84 97.52 97.57
Operating Income 14,117 13,663 13,619 13,063 13,227 14,157 14,621 15,128 15,443 15,742 15,344 14,469 14,370 14,073 12,546 11,650 9,660 8,019 9,334 9,340
Change (%) -3.22 -0.32 -4.08 1.26 7.03 3.28 3.47 2.08 1.94 -2.53 -5.70 -0.68 -2.07 -10.85 -7.14 -17.08 -16.99 16.40 0.06
% of Revenue 5.32 5.10 5.04 4.71 4.66 4.87 4.89 4.93 4.91 4.89 4.65 4.28 4.15 3.95 3.49 3.22 2.63 2.16 2.48 2.43
Interest Expense -2,963 -2,907 -2,831 -2,702 -2,573 -2,503 -2,432 -2,379 -2,343 -2,287 -2,290 -2,393 -2,520 -2,658 -2,785 -2,831 -2,890 -2,958 -3,027 -3,058
Change (%) -1.89 -2.61 -4.56 -4.77 -2.72 -2.84 -2.18 -1.51 -2.39 0.13 4.50 5.31 5.48 4.78 1.65 2.08 2.35 2.33 1.02
% of Revenue -1.12 -1.09 -1.05 -0.97 -0.91 -0.86 -0.81 -0.78 -0.75 -0.71 -0.69 -0.71 -0.73 -0.75 -0.77 -0.78 -0.79 -0.80 -0.80 -0.80
Net Income 7,953 7,179 7,395 7,203 7,577 8,001 8,041 8,287 3,283 4,311 4,093 2,965 8,632 8,344 7,321 7,190 5,016 4,614 5,280 4,531
Change (%) -9.73 3.01 -2.60 5.19 5.60 0.50 3.06 -60.38 31.31 -5.06 -27.56 191.13 -3.34 -12.26 -1.79 -30.24 -8.01 14.43 -14.19
% of Revenue 3.00 2.68 2.74 2.60 2.67 2.75 2.69 2.70 1.04 1.34 1.24 0.88 2.49 2.34 2.04 1.99 1.37 1.24 1.40 1.18

Source: Capital IQ

Other Listings
MX:CVS
PE:CVS
GB:0HRS US$ 74.00
IT:1CVS € 62.84
US:CVS US$ 73.78
GB:CVSD
DE:CVS € 63.17
AT:CVS
CL:CVSCL
CL:CVS
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista